Tale Of Two Healthcare Tech Firms: One Seeks Public Debut Another Looks For Buyer
Portfolio Pulse from Vandana Singh
NextGen Healthcare Inc (NASDAQ:NXGN) is reportedly exploring strategic options, including a potential sale of the company. The healthcare software solutions provider has hired Morgan Stanley to advise on discussions with potential buyers. The decision comes amidst a surge in healthcare sector dealmaking. Meanwhile, NextGen's rival, Waystar, is preparing for an IPO with a valuation of up to $8 billion. NextGen's shares have declined 9% YTD, underperforming the Nasdaq Composite Index's 32% rise.
August 23, 2023 | 7:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has been hired by NextGen Healthcare to advise on discussions with potential buyers.
Morgan Stanley's role as an advisor to NextGen Healthcare could potentially impact its stock price, depending on the outcome of the potential sale. However, as an advisor, the impact is likely to be less direct compared to NextGen Healthcare.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
NextGen Healthcare is exploring strategic options, including a potential sale. The company's shares have declined 9% YTD, underperforming the Nasdaq Composite Index's 32% rise.
The news of NextGen exploring a potential sale could create uncertainty among investors, potentially impacting the stock price. However, the company's underperformance compared to the Nasdaq Composite Index could also be a factor in the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100